Lung Cancer
Volume 62, Issue 1 , Pages 92-98 , October 2008

Interruptions of once-daily thoracic radiotherapy do not correlate with outcomes in limited stage small cell lung cancer: Analysis of CALGB phase III trial 9235

  • Jeffrey A. Bogart

      Affiliations

    • SUNY Upstate Medical University, Radiation Oncology Department, 750 E. Adams Street, Syracuse, NY 13210, United States2
    • For Cancer and Leukemia Group B (Chicago, IL) and Quality Assurance Review Center (Providence, RI).
    • Corresponding Author InformationCorresponding author. Tel.: +1 315 464 5276; fax: +1 315 464 5939.
    • ,
  • Dorothy Watson

      Affiliations

    • CALGB Statistical Center, Duke University Medical Center, Durham, NC, United States3
    • For Cancer and Leukemia Group B (Chicago, IL) and Quality Assurance Review Center (Providence, RI).
    • ,
  • Edward F. McClay

      Affiliations

    • University of California at San Diego, San Diego, CA, United States4
    • For Cancer and Leukemia Group B (Chicago, IL) and Quality Assurance Review Center (Providence, RI).
    • ,
  • Lisa Evans

      Affiliations

    • Southeast Cancer Control Consortium Inc., CCOP, Goldsboro, NC, United States5
    • For Cancer and Leukemia Group B (Chicago, IL) and Quality Assurance Review Center (Providence, RI).
    • ,
  • James E. Herndon

      Affiliations

    • CALGB Statistical Center, Duke University Medical Center, Durham, NC, United States3
    • For Cancer and Leukemia Group B (Chicago, IL) and Quality Assurance Review Center (Providence, RI).
    • ,
  • Frances Laurie

      Affiliations

    • Quality Assurance Review Center, Independent Laboratories, Providence, RI, United States
    • For Cancer and Leukemia Group B (Chicago, IL) and Quality Assurance Review Center (Providence, RI).
    • ,
  • Stephen L. Seagren

      Affiliations

    • University of California at San Diego, San Diego, CA, United States4
    • For Cancer and Leukemia Group B (Chicago, IL) and Quality Assurance Review Center (Providence, RI).
    • ,
  • T.J. Fitzgerald

      Affiliations

    • Quality Assurance Review Center, Independent Laboratories, Providence, RI, United States
    • For Cancer and Leukemia Group B (Chicago, IL) and Quality Assurance Review Center (Providence, RI).
    • ,
  • Everett Vokes

      Affiliations

    • University of Chicago, Chicago, IL, United States6
    • For Cancer and Leukemia Group B (Chicago, IL) and Quality Assurance Review Center (Providence, RI).
    • ,
  • Mark R. Green

      Affiliations

    • Southeast Cancer Control Consortium Inc., CCOP, Goldsboro, NC, United States5
    • For Cancer and Leukemia Group B (Chicago, IL) and Quality Assurance Review Center (Providence, RI).

Received 19 October 2007 ,Revised 20 January 2008 ,Accepted 9 February 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0169-5002(08)00066-4

doi: 10.1016/j.lungcan.2008.02.006

Lung Cancer
Volume 62, Issue 1 , Pages 92-98 , October 2008

Article Tools

* Image Usage & Resolution